Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00211705
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2005-09-13
Brief Title:
Management of Elevated Cholesterol in the Primary Prevention Group of Adult JapaneseMEGA Study
Sponsor:
Mitsukoshi Health and Welfare Foundation
Organization:
Mitsukoshi Health and Welfare Foundation
Study Overview
Official Title:
Management of Elevated Cholesterol in the Primary Prevention Group of Adult JapaneseMEGA Study
Status:
COMPLETED
Status Verified Date:
2005-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the primary preventive effect of low-dose pravastatin against coronary heart disease CHD in Japanese hypercholesterolemic patients
Detailed Description:
MEGA Study is the first prospective randomized controlled trial conducted in Japan to evaluate the primary preventive effect of pravastatin against CHD in daily clinical practice Because the dose of pravastatin used in the MEGA Study was 10-20 mgday which is consistent with the approved doses in Japan and lower than the doses used in previous large-scale clinical trials
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None